• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经尿道前列腺切除术后性功能障碍的相关因素。

Factors associated with sexual dysfunction following transurethral resection of the prostate.

作者信息

Gilling P J, Wright W L, Gray J M

机构信息

Waikato Hospital, Hamilton.

出版信息

N Z Med J. 1988 Jul 27;101(850):484-5.

PMID:3393344
Abstract

A retrospective analysis of 62 consecutive potent patients undergoing transurethral resection of the prostate is described. Each patient was interviewed a minimum of six months following surgery. Potency was retained in 89% of patients but 57% of these experienced a decrease from their preoperative level of function. Three factors were found to be significantly associated with a reduction in postoperative potency. These were systemic disease (p less than 0.001), small prostatic resections (p less than 0.001) and a reduced level of potency preoperatively (p less than 0.01). Of those men retaining a degree of potency, 90% achieved their first erection within two months of the procedure. The full extent of sexual dysfunction following transurethral resection of the prostate has not previously been appreciated, nor have the factors associated with this dysfunction.

摘要

本文描述了对62例连续接受经尿道前列腺切除术的性功能正常患者的回顾性分析。每位患者在术后至少接受了六个月的随访。89%的患者保留了性功能,但其中57%的患者性功能较术前水平有所下降。发现有三个因素与术后性功能下降显著相关。这些因素是全身性疾病(p<0.001)、小范围前列腺切除术(p<0.001)和术前性功能水平降低(p<0.01)。在保留一定程度性功能的男性中,90%在术后两个月内实现了首次勃起。经尿道前列腺切除术后性功能障碍的全部程度此前未被充分认识,与此功能障碍相关的因素也未被充分认识。

相似文献

1
Factors associated with sexual dysfunction following transurethral resection of the prostate.经尿道前列腺切除术后性功能障碍的相关因素。
N Z Med J. 1988 Jul 27;101(850):484-5.
2
Erectile dysfunction following transurethral resection of the prostate.
J Urol. 1996 Oct;156(4):1354-6.
3
Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.保留性神经的耻骨后根治性前列腺切除术后,术后阴茎大小得以保留与勃起功能维持良好相关。
Eur Urol. 2007 Sep;52(3):702-7. doi: 10.1016/j.eururo.2007.03.050. Epub 2007 Mar 26.
4
Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests.
J Urol. 1995 May;153(5):1491-3.
5
Is laparoscopic unilateral sural nerve grafting during radical prostatectomy effective in retaining sexual potency?根治性前列腺切除术中腹腔镜下单侧腓肠神经移植术在保留性功能方面是否有效?
BJU Int. 2005 Jun;95(9):1267-71. doi: 10.1111/j.1464-410X.2005.05501.x.
6
Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy.双侧保留神经的耻骨后根治性前列腺切除术候选者的基线效能
Eur Urol. 2006 Aug;50(2):360-5. doi: 10.1016/j.eururo.2005.12.007. Epub 2006 Jan 4.
7
Erectile function durability following permanent prostate brachytherapy.永久性前列腺近距离放射治疗后的勃起功能持久性
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):639-48. doi: 10.1016/j.ijrobp.2008.11.058. Epub 2009 Mar 21.
8
Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy.患者与伴侣之间的年龄差异是根治性前列腺切除术后性功能恢复率的一个预测因素。
J Urol. 2006 Dec;176(6 Pt 1):2594-8; discussion 2598. doi: 10.1016/j.juro.2006.07.145.
9
Factors predicting recovery of erections after radical prostatectomy.根治性前列腺切除术后勃起功能恢复的预测因素。
J Urol. 2000 Dec;164(6):1929-34.
10
Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.经尿道前列腺切除术对良性前列腺增生患者生活质量的影响。
J Am Coll Surg. 2004 Mar;198(3):394-403. doi: 10.1016/j.jamcollsurg.2003.10.016.

引用本文的文献

1
Repetitive prostatic massage and drug therapy as an alternative to transurethral resection of the prostate.重复前列腺按摩和药物治疗作为经尿道前列腺切除术的替代方法。
MedGenMed. 2006 Oct 25;8(4):19.
2
Annual costs of benign prostatic hyperplasia in New Zealand.
Pharmacoeconomics. 1993 Dec;4(6):455-68. doi: 10.2165/00019053-199304060-00007.